HE 20.4702:C 17/3/DRAFT
|
Guidance for industry statistical aspects of the design, analysis, and interpretation of chronic rodent carcinogenicity studies of pharmaceuticals. |
1 |
HE 20.4702:C 33
|
Manual del Centro para la Evaluacion e Investigacion de Farmacos |
1 |
HE 20.4702:C 33/2
|
Guidance for sponsors, industry, researchers, investigators, and Food and Drug Administration staff certifications to accompany drug, biological product and device applications/submissions : compliance with Section 402(j) of the Public Health Service Act, added by Title VIII of the Food and Drug Administration Amendments Act of 2007. |
1 |
HE 20.4702:C 42
|
Guidance for industry format and content for the CMC section of an annual report. |
1 |
HE 20.4702:C 43
|
Cómo darles la medicina a los niños |
1 |
HE 20.4702:C 46
|
Reviewer guidance validation of chromatographic methods. |
1 |
HE 20.4702:C 61
|
Guidance for industry E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. |
1 |
HE 20.4702:C 61/2
|
Guidance for industry E 11 clinical investigation of medicinal products in the pediatric population. |
1 |
HE 20.4702:C 61/3
|
Guidance for industry E6 good clinical practice, consolidated guidance. |
1 |
HE 20.4702:C 61/4
|
Guidance for industry acceptance of foreign clinical studies. |
1 |
HE 20.4702:C 61/5
|
Reviewer guidance conducting a clinical safety review of a new product application and preparing a report on the review. |
1 |
HE 20.4702:C 61/6
|
Guidance for industry E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs, questions and answers. |
1 |
HE 20.4702:C 62
|
Guidance for industry clozapine tables, in vivo bioequivalence and in vitro dissolution testing. |
1 |
HE 20.4702:C 62/2
|
Guidance for industry container closure systems for packaging human drugs and biologics. |
1 |
HE 20.4702:C 62/3
|
Guidance for industry container closure systems for packaging human drugs and biologics, questions and answers. |
1 |
HE 20.4702:C 67
|
Cómo tratar los resfriados y la influenza |
1 |
HE 20.4702:C 73
|
Guidance for industry M4, the CTD, efficacy questions and answers. |
1 |
HE 20.4702:C 73/2
|
Guidance for industry M4, the CTD, general questions and answers. |
1 |
HE 20.4702:C 73/3
|
Guidance for industry M4E, the CTD, efficacy. |
1 |
HE 20.4702:C 73/4
|
Guidance for industry M4Q, the CTD, quality. |
1 |